The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 1 , Pages 146-153 , January 2010

Acute right ventricular failure after pediatric cardiac transplant: Predictors and long-term outcome in current era of transplantation medicine

  • Aparna Hoskote, MD, MRCP

      Affiliations

    • Cardiac Critical Care Unit, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
    • Corresponding Author InformationAddress for reprints: Aparna Hoskote, MD, MRCP, Consultant in Cardiac Critical Care, Cardiac Critical Care Unit, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1N 1JH, United Kingdom.
    • ,
  • Catherine Carter, MSc, MPH, RN

      Affiliations

    • Cardiothoracic Transplant Medicine, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
    • ,
  • Phillip Rees, MB, FRCP

      Affiliations

    • Cardiothoracic Transplant Medicine, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
    • ,
  • Martin Elliott, MD, FRCS

      Affiliations

    • Cardiothoracic Surgery, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
    • ,
  • Michael Burch, MD, FRCP, FRCPCH

      Affiliations

    • Cardiothoracic Transplant Medicine, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
    • ,
  • Katherine Brown, MPH, MRCP

      Affiliations

    • Cardiac Critical Care Unit, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

Received 23 December 2008 ,Revised 3 July 2009 ,Accepted 10 August 2009.

References 

  1. Chen JM, Levin HR, Michler RE, Prusmack CJ, Rose EA, Aaronson KD. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg. 1997;114:627–634
  2. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48–54
  3. Trento A, Griffith BP, Fricker FJ, Kormos RL, Armitage J, Hardesty RL. Lessons learned in pediatric heart transplantation. Ann Thorac Surg. 1989;48:617–622discussion 622-3
  4. Hehrlein FW, Netz H, Moosdorf R, Dapper F, Scheld HH, Bauer J, et al. Pediatric heart transplantation for congenital heart disease and cardiomyopathy. Ann Thorac Surg. 1991;52:112–117
  5. Tamisier D, Vouhe P, Le Bidois J, Mauriat P, Khoury W, Leca F. Donor-recipient size matching in pediatric heart transplantation: a word of caution about small grafts. J Heart Lung Transplant. 1996;15:190–195
  6. Boucek RJ, Boucek MM. Pediatric heart transplantation. Curr Opin Pediatr. 2002;14:611–619
  7. Coskun O, Parsa A, Coskun T, El Arousy M, Blanz U, Von Knyphausen E, et al. Outcome of heart transplantation in pediatric recipients: experience in 128 patients. ASAIO J. 2007;53:107–110
  8. Morales DL, Dreyer WJ, Denfield SW, Heinle JS, McKenzie ED, Graves DE, et al. Over two decades of pediatric heart transplantation: how has survival changed?. J Thorac Cardiovasc Surg. 2007;133:632–639
  9. Sweet SC, Wong HH, Webber SA, Horslen S, Guidinger MK, Fine RN, et al. Pediatric transplantation in the United States, 1995–2004. Am J Transplant. 2006;6(5 Pt 2):1132–1152
  10. Fukushima N, Gundry SR, Razzouk AJ, Bailey LL. Risk factors for graft failure associated with pulmonary hypertension after pediatric heart transplantation. J Thorac Cardiovasc Surg. 1994;107:985–989
  11. George I, Xydas S, Topkara VK, Ferdinando C, Barnwell EC, Gableman L, et al. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg. 2006;82:2161–2169
  12. Huang J, Trinkaus K, Huddleston CB, Mendeloff EN, Spray TL, Canter CE. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. J Heart Lung Transplant. 2004;23:716–722
  13. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report—2000. J Heart Lung Transplant. 2000;19:909–931
  14. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 1999;34:1802–1806
  15. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol. 1995;25:1656–1664
  16. Fenton MJ, Chubb H, McMahon AM, Rees P, Elliott MJ, Burch M. Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children. Heart. 2006;92:85–89
  17. Kimberling MT, Balzer DT, Hirsch R, Mendeloff E, Huddleston CB, Canter CE. Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome. J Heart Lung Transplant. 2002;21:455–459
  18. Weller RJ, Weintraub R, Addonizio LJ, Chrisant MR, Gersony WM, Hsu DT. Outcome of idiopathic restrictive cardiomyopathy in children. Am J Cardiol. 2002;90:501–506
  19. Mitchell MB, Campbell DN, Boucek MM. Heart transplantation for the failing Fontan circulation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:56–64
  20. Bernstein D, Naftel D, Chin C, Addonizio LJ, Gamberg P, Blume ED, et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114:273–280
  21. Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK, et al. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;115:658–676
  22. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 2004;25:2243–2278
  23. Bando K, Konishi H, Komatsu K, Fricker FJ, del Nido PJ, Francalancia NA, et al. Improved survival following pediatric cardiac transplantation in high-risk patients. Circulation. 1993;88(5 Pt 2):II218–II223
  24. Hsu DT, Quaegebeur JM, Michler RE, Smith CR, Rose EA, Kichuk MR, et al. Heart transplantation in children with congenital heart disease. J Am Coll Cardiol. 1995;26:743–749
  25. Kirklin JK, Naftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol. 1988;11:917–924
  26. Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy PS, Denys BG, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993;126:896–904
  27. Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg. 1991;101:432–444discussion 444-5
  28. Vouhe PR, Tamisier D, Leca F, Le Bidois J, Khoury W, Mauriat P, et al. Heart transplantation in children: risk factors of early and late mortality. Eur J Cardiothorac Surg. 1991;5:176–180discussion 181-2
  29. Bhatia SJ, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ, et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 1987;76:819–826
  30. Gajarski RJ, Towbin JA, Bricker JT, Radovancevic B, Frazier OH, Price JK, et al. Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol. 1994;23:1682–1687
  31. Webber SA. The current state of, and future prospects for, cardiac transplantation in children. Cardiol Young. 2003;13:64–83
  32. Zales VR, Pahl E, Backer CL, Crawford S, Mavroudis C, Benson DW. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. J Heart Lung Transplant. 1993;12(6 Pt 1):965–972discussion 972-3
  33. Boffa GM, Razzolini R, Grassi G, Basso C, Ramondo A, Isabella G, et al. Pulmonary vascular resistance variation over time in candidates for heart transplantation. Am J Cardiol. 1994;73:414–415
  34. Maruszewski M, Zakliczynski M, Przybylski R, Kucewicz-Czech E, Zembala M. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure. Transplant Proc. 2007;39:2850–2852
  35. Gandhi SK, Grady RM, Huddleston CB, Balzer DT, Canter CE. Beyond Berlin: heart transplantation in the “untransplantable.”. J Thorac Cardiovasc Surg. 2008;136:529–531
  36. Marasco SF, Esmore DS, Richardson M, Bailey M, Negri J, Rowland M, et al. Prolonged cardiac allograft ischemic time—no impact on long-term survival but at what cost?. Clin Transplant. 2007;21:321–329
  37. Morgan JA, John R, Park Y, Addonizio LJ, Oz MC, Edwards NM, et al. Successful outcome with extended allograft ischemic time in pediatric heart transplantation. J Heart Lung Transplant. 2005;24:58–62
  38. Scheule AM, Zimmerman GJ, Johnston JK, Razzouk AJ, Gundry SR, Bailey LL. Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Circulation. 2002;106(12 Suppl. 1):I163–I167
  39. Costanzo-Nordin MR, Liao YL, Grusk BB, O'Sullivan EJ, Cooper RS, Johnson MR, et al. Oversizing of donor hearts: beneficial or detrimental?. J Heart Lung Transplant. 1991;10(5 Pt 1):717–730
  40. Kieler-Jensen N, Lundin S, Ricksten SE. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant. 1995;14:436–443
  41. Williams TJ, Salamonsen RF, Snell G, Kaye D, Esmore DS. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant. 1995;14:419–423
  42. Auler Junior JO, Carmona MJ, Bocchi EA, Bacal F, Fiorelli AI, Stolf NA, et al. Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant. 1996;15:443–450
  43. Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72:638–641
  44. Bauer J, Dapper F, Demirakca S, Knothe C, Thul J, Hagel KJ. Perioperative management of pulmonary hypertension after heart transplantation in childhood. J Heart Lung Transplant. 1997;16:1238–1247
  45. Schindler E, Muller M, Akinturk H, Valeske K, Bauer J, Zickmann B, et al. Perioperative management in pediatric heart transplantation from 1988 to 2001: anesthetic experience in a single center. Pediatr Transplant. 2004;8:237–242
  46. Shaddy RE. Pulmonary hypertension in pediatric heart transplantation. Prog Pediatr Cardiol. 2000;11:131–136
  47. Butler J, Stankewicz MA, Wu J, Chomsky DB, Howser RL, Khadim G, et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant. 2005;24:170–177

PII: S0022-5223(09)01074-5

doi: 10.1016/j.jtcvs.2009.08.020

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 1 , Pages 146-153 , January 2010

Article Tools

* Image Usage & Resolution